Literature DB >> 12207622

Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread.

S Ugurel, A Wagner, C Pföhler, W Tilgen, U Reinhold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12207622     DOI： 10.1046/j.1365-2133.2002.488811.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Subcutaneous metastases from melanoma: a discussion of clinical experience.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Katarzyna Kozak
Journal:  Melanoma Manag       Date:  2014-09-05

2.  Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.

Authors:  Kristin Turza; Lynn T Dengel; Rebecca C Harris; James W Patterson; Kevin White; William W Grosh; Craig L Slingluff
Journal:  J Cutan Pathol       Date:  2009-07-07       Impact factor: 1.587

3.  [Complete remission of cutaneous satellite and in-transit metastases. After intralesional therapy with interleukin-2 in 2 patients with malignant melanoma].

Authors:  C Pföhler; S Steinhäuser; A Wagner; S Ugurel; W Tilgen
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

4.  Application of CO2 laser evaporation in locally advanced melanoma.

Authors:  Otis M Vrielink; Schelto Kruijff; Barbara L van Leeuwen; Jan Ln Roodenburg
Journal:  Melanoma Manag       Date:  2019-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.